Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

STARD13 anticorps (AA 544-573)

STARD13 Reactivité: Humain WB Hôte: Lapin Polyclonal RB40830 unconjugated
N° du produit ABIN1881846
  • Antigène Voir toutes STARD13 Anticorps
    STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
    Épitope
    • 6
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    AA 544-573
    Reactivité
    • 23
    • 6
    • 2
    Humain
    Hôte
    • 23
    Lapin
    Clonalité
    • 23
    Polyclonal
    Conjugué
    • 9
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp STARD13 est non-conjugé
    Application
    • 16
    • 12
    • 6
    • 3
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.
    Clone
    RB40830
    Isotype
    Ig Fraction
    Top Product
    Discover our top product STARD13 Anticorps primaire
  • Indications d'application
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Date de péremption
    6 months
  • Zhang, Wang, Hu: "STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas." dans: Biotechnology letters, Vol. 39, Issue 2, pp. 207-217, (2017) (PubMed).

    Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." dans: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

  • Antigène
    STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
    Autre désignation
    STARD13 (STARD13 Produits)
    Synonymes
    anticorps ARHGAP37, anticorps DLC2, anticorps GT650, anticorps LINC00464, anticorps RGD1564816, anticorps StAR related lipid transfer domain containing 13, anticorps StAR-related lipid transfer (START) domain containing 13, anticorps StAR-related lipid transfer domain containing 13, anticorps STARD13, anticorps Stard13
    Sujet
    This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.
    Poids moléculaire
    124967
    NCBI Accession
    NP_001230395, NP_001230403, NP_001230405, NP_443083, NP_821074, NP_821075
    UniProt
    Q9Y3M8
Vous êtes ici:
Support technique